专利号:WO-2025062384-A2 优先权日:2023-09-23 标题 :A method for synthesis of metal halide perovskite (cspbbr3) nano/microcrystals 发明人:M A GOKUL; RAHMAN ATIKUR 权利人:INDIAN INSTITUTE OF SCIENCE EDUCATION AND RES PUNE IISER PUNE 摘要:The present invention relates to metal halide perovskite (CsPbBr3) nano/microcrystals. Specifically, the present invention relates to a method for the synthesis of metal halide perovskite (CsPbBr3) nano/microcrystals. The present invention uses an easy, scalable low temperature growth of metal halide nanoparticles like CsPbBr3. The method uses a clever play on the solubility and ion exchange mechanism to precipitate nano and microcrystals of metal halide perovskites. The synthesis resulted in stable perovskite crystals with high photo- luminescence, ultralow dark current and control over their morphology. The combination of ultralow dark current, high responsivity, exceptional detectivity, and broad-band photon detection capabilities makes these crystals an excellent choice for upcoming sensors and detector technologies.
专利号:WO-2024137710-A3 优先权日:2022-12-19 标 题 :Improved enzymes and methods for the synthesis of cannabinoids 发明人:KAMBOURAKIS SPIROS; KOMOR RUSSELL SCOTT; CAIAZZA NICKY CHRISTOPHER; KEUL NICHOLAS DONALD; WALKER CALEB MARSHALL 权利人:CELLIBRE INC 摘要:Disclosed herein are novel CBGA and CBGVA synthases and methods for improvement of their overall activities for the synthesis of CBGA and CBGVA from their respective precursors, olivetolic acid (OA) or divarinic acid (DVA) and GPP. Also disclosed are fusion proteins to enhance synthesis of CBGA and CBGVA. The methods described herein also increase the titer and the purity of CBGA and CBGVA made by a cell by 1) decreasing the formation of byproducts FCBGA and FCBGVA that are synthesized from the respective prenylation of OA and DVA with FPP, 2) increasing the intracellular availability of OA and DVA and 3) increasing the speed of CBGA and CBGVA formation, while reducing accumulation of intermediates.
专利号:US-12391691-B2 优先权日:2018-11-16 标题:Synthesis of key intermediate of KRAS G12C inhibitor compound 发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY 权利人:AMGEN INC 摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as
专利号:US-2025206736-A1 优先权日:2019-11-14 标题 :Synthesis of kras g12c inhibitor compound 发明人:CORBETT MICHAEL THOMAS; CAILLE SEBASTIEN 权利人:AMGEN INC 摘要:The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2-isopropyl-4-methylpyridin-3-amine, useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.
专利号:US-2025171686-A1 优先权日:2023-11-27 标题 :Room temperature ambient synthesis of metal-doped halide perovskite nanocrystals 发明人:FELDMANN SASCHA; WUTTIG MATEO CARDENES; VANORMAN ZACHARY 权利人:ECOLE POLYTECHNIQUE FED LAUSANNE EPFL; PRESIDENT AND FELLOWS OF HARVARD COLLEGE CAMBRIDGE MA 摘要:A method of preparing a composition including crystalline particles of a halide perovskite, a composition and a perovskite-based device including the same. The halide perovskite has a chemical formula ABX3, wherein A is a monocation, B is selected from a combination of lead (II) and a dopant and X is selected from a halide.
专利号:US-2025206743-A1 优先权日:2022-03-25 标 题:Tyk2 inhibitor synthesis and intermediates thereof 发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG 权利人:TAKEDA PHARMACEUTICALS CO 摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.
1: Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. J Cancer Res Clin Oncol. 2017 Sep 23. doi: 10.1007/s00432-017-2515-2. [Epub ahead of print] Review. Review. Japanese. pii: E272. doi: 10.3390/toxins8100272. Review. 4: Wakimoto T, Egami Y, Abe I. Calyculin: Nature's way of making the sponge-derived cytotoxin. Nat Prod Rep. 2016 Jun 2;33(6):751-60. doi: 10.1039/c5np00123d. Review. doi: 10.1021/acs.jnatprod.5b01066. Epub 2016 Feb 22. Review. doi: 10.3390/md13106505. Review. 7: Zimmer ER, Leuzy A, Souza DO, Portela LV. Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System. Mol Neurobiol. 2016 Aug;53(6):3753-3755. doi: 10.1007/s12035-015-9321-0. Epub 2015 Jul 4. Review. doi: 10.1186/s12974-015-0291-y. Review.
合成参考文献
摘要:Journal of the American Chemical Society., 103(2469), 1981